Literature DB >> 1388353

Cardiovascular disease in patients with end-stage renal failure.

S C Greaves1, D N Sharpe.   

Abstract

Entities:  

Mesh：

Year:  1992        PMID： 1388353     DOI： 10.1111/j.1445-5994.1992.tb02797.x

Source DB:  PubMed          Journal:  Aust N Z J Med        ISSN： 0004-8291


× No keyword cloud information.
  3 in total

Review 1.  Risk-benefit ratio of angiotensin antagonists versus ACE inhibitors in end-stage renal disease.

Authors:  D A Sica; T W Gehr; A Fernandez
Journal:  Drug Saf       Date:  2000-05       Impact factor: 5.606

2.  Abnormal left ventricular mass and aortic distensibility in pediatric dialysis patients.

Authors:  Renee F Robinson; Milap C Nahata; Elizabeth Sparks; Curt Daniels; Donald L Batisky; John R Hayes; John D Mahan
Journal:  Pediatr Nephrol       Date:  2004-10-27       Impact factor: 3.714

3.  Effect of supplementation of vitamin E, vitamin C and reduced glutathione on copper ion induced lipoprotein oxidation in renal diseased patients-Anin vitro study.

Authors:  C S Parameswari; B Vijayageetha; R Vijayakumar
Journal:  Indian J Clin Biochem       Date:  2006-03
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.